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ABSTRACT
Rhabdomyosarcoma (RMS) is a malignant soft tissue neoplasm consisting of cells derived from the primitive mesen-
chyme that exhibit a profound tendency to myogenesis. About 35% of RMS arises in the head and neck, being classified 
as parameningeal and non-orbital non-parameningeal forms. Parameningeal tumors carry the worst prognosis. The 
use of contemporary, multi-agent chemotherapy, radiotherapy, and surgery has made treatment of the disseminated 
disease possible, and has significantly improved overall survival from 25% in 1970 to 70% in 1991. Here, we present the 
management of two cases of orofacial RMS in adolescents: an 18-year-old, white female that had a 9-month history 
of a nodule in the left buccal mucosa, and a 19-year-old, white male who had been aware of a nodule in the left, pos-
terior maxillary ridge with progressive growth for 4 months. Before final diagnosis, both cases were previously treated 
as inflammatory lesions. Their clinicopathological aspects, treatment, and poor survival as a consequence of delays in 
diagnosis are discussed.
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INTRODUCTION 
Rhabdomyosarcoma (RMS) is a malignant, soft tissue 
neoplasm consisting of cells derived from the primitive me-
senchyme that exhibit a profound tendency to myogenesis. 
(1)  Each year, 4.6 per million U.S. children and adolescents 
younger than 20 years of age are diagnosed with RMS. (2) 
In Brazil, the estimated incidence is 7.8 per million children 
under 15 years of age. (3) The use of contemporary, multi-
agent chemotherapy, radiotherapy, and surgery has made 
treatment of  the disseminated disease possible, and has 
significantly improved overall survival from 25% in 1970 
to 70% in 1991. (4)
About 35% of RMS arises in the head and neck. According 
to their anatomical location and propensity for invasion of 
the central nervous system, these RMSs are divided in orbital, 
parameningeal and non-orbital non-parameningeal forms. 
Parameningeal tumors carry the worst prognosis. (4)
The histopathological and molecular spectrum manifested 
by RMS has led to many classification systems.  These 
differing morphological features were recognized in the 
mid-1900s by Horn and Enterline who divided rhabdom-
yosarcomas into embryonal (ERMS), alveolar, botryoid, 
and pleomorphic subtypes. (1,5)  Thus, a proliferation of 
subtle differences in diagnostic criteria had developed. (1) 
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In 1994, histological and biological studies have resulted in 
the International Classification of RMS into prognostically 
significant and diagnostically consistent subgroups based on 
the level of agreement and power of prognostic prediction. 
Four broad subtypes of RMS were established: (a) botr-
yoid and spindle cell RMS (both less common variants of 
ERMS); (b) embryonal RMS, generally having a superior 
prognosis; (c) alveolar (including the solid-alveolar variant) 
RMS, generally having a poorer prognosis and (d) undiffe-
rentiated sarcoma, also generally having a poorer prognosis. 
Finally, a category of sarcoma nor otherwise specified was 
created for tumors that could not be classified into an speci-
fic subtype. (1,5) Recently it was added to this classification 
a subtype of RMS with rhabdoid-like features, whose prog-
nosis is not presently valuable. (6)  It is now apparent that 
rhabdomyosarcoma comprises a group of morphologically 
similar but biologically diverse lesions. (1)
Here, we present the management of two cases of orofacial 
RMS in adolescents, and discuss their clinicopathological 
aspects, treatment, and poor survival of these as a conse-
quence of delays in diagnosis.
CASE REPORTS
Case 1
The Pediatric Institute – GRAACC is a branch of  the 
Medical School of São Paulo of the Federal University of 
São Paulo. Before beginning  any procedures, the patients 
or their guardians receive a detailed, informed consent form 
that the case may be used for didatic purposes. Only those 
who sign the form, of their own free will are included in 
published reports or study groups.
An 18-year-old, white female had a 9-month history of a 
nodule in the left buccal mucosa. Initially, she consulted her 
dentist, who performed a dental extraction. Subsequently, at 
the same site, she noted a painless slowly-growing swelling, 
and one month later she was submitted to an incisional 
biopsy that disclosed a histological diagnosis of  “solid 
alveolar rhabdomyosarcoma”.  The patient was treated 
employing VAC chemotherapy (vincristine, actinomycin-D, 
cyclophosphamide) alternated with ifosfamide/vepeside, and 
complementary radiotherapy, receiving 3600 cGy. The tumor 
progressed and the patient was referred to our service.  
Fig. 1A. Front view of the patient, showing asymmetry of the left cheek 
caused by the tumoral mass.
Fig. 1B. Computerized tomographic (CT) scan shows an expanding mass 
filling the maxillary sinus, with bone destruction and displacement of 
adjacent structures like the temporomandibular joint and auditory canal. 
Note that the mandibular ramus is also destroyed.
Fig. 1C. Photomicrograph of the undifferentiated sarcoma showing diffuse, 
closely packed, large round cells with scanty to moderate cytoplasm and 
with nuclei that typically are larger than those seen in other RMS. Note the 
mitosis figure, frequently seen in these neoplasms (asterisk) (Hematoxylin 
and eosin stain. Original magnification 100X).
Fig. 1D. Other aspect of the tumor showing small, round cells in a stroma-
rich with no evidence of alveolar pattern or any characteristic architectural 
appearance. The tumor failed to express antigenic markers (Hematoxylin 
and eosin stain. Original magnification 100X).
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At the time of admission, the patient exhibited an extensive 
swelling in the oral cavity with imminent airway obstruction. 
A tracheostomy was performed immediately (Figure 1A). 
An intra-oral exam was not possible owing to the extent 
of the tumor. Computerized tomography scans showed an 
infiltrative soft tissue mass causing maxillary destruction and 
displacement of the adjacent structures (Figure 1B). Metas-
tasis screenings indicated liver and pulmonary involvement. 
Revision of the biopsy material confirmed the diagnosis of 
RMS but the subtype was changed to “undifferentiated sar-
coma” due its negativity to immunohistochemical tests for 
myogenin, desmin, muscle-specific actin, leukocyte common 
antigen and cytokeratins (Figures 1C and 1D). Chemothera-
py with topotecan, navelbin, carboplatin and vepeside was 
initiated resulting in the partial regression of the tumor. The 
patient also received complementary radiotherapy, reaching 
7300 cGy in the oral cavity and 1200 cGy in the lung.  The 
patient died from respiratory failure caused by metastases in 
lung 20 months after admission to our service.   
Case 2
A 19-year-old, white male had been aware of a nodule in 
the left, posterior maxillary ridge with progressive growth 
for 4 months. Initially, the patient was seen by a physician 
who prescribed antibiotic/anti-inflammatory therapy.  After 
two months an unsuccessful attempt was made to drain the 
lesion. A biopsy was performed and a “malignant tumor” in-
dicated.  At the time of admission to our service, the patient 
presented facial asymmetry with an asymptomatic, fetid 
swelling on the left side (Figure 2A). Intra-oral examination 
showed a 5 x 6 cm, red, firm mass with grayish areas of cen-
tral necrosis, covering the left side of the maxillary gingiva, 
from the central incisor to the second molar (Figures 2B 
and 2C).  The teeth involved in the mass showed mobility 
although the patient still could talk and feed properly.  
Fig. 2A. Front view of the 
patient showing discrete 
swelling on the left side, 
elevation of  the nasal ala 
and displacement of  the 
incisor.
Fig. 2B. Intra-oral exami-
nation shows the palate 
exhibiting an irregular, 5 
x 6 cm mass with areas of 
necrosis.
Fig. 2C. A view of the tu-
mor extending to the left 
maxillary gingiva. 
Fig. 3A. Computerized tomographic (CT) axial image of the tumor showing 
the irregular destruction of the maxillary bone and the vestibular extension 
of tumoral mass (asterisks).
Fig. 3B. This CT shows involvement of  the antrum, nasal cavity and 
maxillary sinus (asterisks) with partial destruction of its walls and dis-
placement of the teeth.
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Computerized tomography scans revealed an irregular 
destruction of the maxillary bone (Figures 3A and 3B). 
Findings by computerized chest tomographies, complete 
blood cell count, and blood chemistry were all within normal 
limits.  An incisional biopsy was performed, and the speci-
mens disclosed embryonal rhabdomyosarcoma (Figure 3C). 
The immunohistochemical tests were positive for desmin, 
vimentin and muscle actin, and negative for cytokeratins 
and S100 protein (Figure 3D).  Myogenin showed a cyto-
plasmic and nonspecific background staining. The patient 
began a combined VAC chemotherapy consisting of cyclo-
phosphamide, vincristine and actinomycin-D; however, the 
tumor continued to spread, and after four cycles reached 6 
x 8 cm.  The treatment protocol was altered to topotecan, 
navelbine, ifosfamide, and vepeside, with an associated dose 
of radiotherapy (5040 cGy).  The tumor increased in size 
despite treatment, and the patient died from lung metastases 
8 months after admission to the service.  
DISCUSSION 
Oral rhabdomyosarcomas are classified within the non-
parameningeal group of  tumors, which present a better 
prognosis and tend not to invade the central nervous system. 
(4) Further, with the advent of combined surgical, chemo-
therapeutic, and radiotherapeutic management of RMS, the 
five-year survival rate is approximately 85% for this RMS 
subtype. (7) Even so, we present two new cases of oral rha-
bdomyosarcoma in adolescents with a fatal outcome. 
The young man exhibited embryonal RMS, no metastases 
on initial treatment, and an 8-month survival period after 
admission to our service. On the other hand, the woman 
suffered from an undifferentiated sarcoma with metastases 
at admission, dying 20 months later. The opposite outcome 
would be expected. This is a conflicting data with the lite-
rature (7-9), and we did not have the possibility to perform 
molecular pathology investigations, but they may have 
answered our question about the survival of the patients. 
Recent studies suggest that the application of molecular 
pathology to classification of  RMS subtypes may help 
to resolve some of these controversies by the use of more 
objective criteria based on genetic differences between the 
subtypes of RMS. For example, it has been described that 
patients with the variant PAX7-FKHR translocation have a 
more favorable prognosis than do those with the more com-
mon PAX3-FKHR translocation. Even more intriguing is 
a preliminary report suggesting a strikingly better outcome 
among patients with metastatic disease and variant-trans-
location-positive alveolar RMS (estimated 4-year overall 
survival, 75% vs. 8% for patients with PAX3-FKHR-positive 
alveolar RMS). (8) 
Although myogenin is considered a sensitive and specific 
marker for RMS, more specific than desmin and muscle-
specific actin and more sensitive than myoglobin, (10) in 
our cases, clinicopathological data, morphology and the 
immunohistochemical panel were more useful in the RMS 
diagnosis than myogenin alone.
The incidence of RMS is highest in children 1-4 years of 
age, falling to a lower rate at 10-14 years, and remaining 
steady between 15-19 years of  age. (11)  This tumor is 
usually fast-growing and infiltrative, and often appears as 
an enlarging, painless mass.  Initial symptoms may be vague, 
and may mimic other childhood and adolescent, soft-tissue 
sarcomas such as fibrosarcoma, leiomyosarcoma and neu-
rofibrosarcoma. (12)
Bras et al. (1987) found that of 12 patients with RMS, the 
interval between the first symptoms and biopsy ranged from 
0 to 26 weeks, with a median of 7 weeks and an average 
of 7.4 weeks. (13) In most cases, when initially examined, 
the patients already exhibit large tumors due to their rapid 
growth and the frequent delay in medical consultation. 
Since the late 1970´s it is believed that suspected infection 
constitutes an important cause of the delay in RMS diag-
nosis. (13)  Our patient cases confirm this finding, although, 
given the lack of inflammatory symptoms in both cases, 
there was a misdiagnosis of dental abscess or pulpitis.  This 
misdiagnosis delayed the patients´ diagnoses for 3 months, 
Fig. 3 C. Embryonal RMS with a zone of stroma-rich, dense, 
small round cell appearance separated by small amounts of 
interstitial collagen (Hematoxylin and eosin stain. Original 
magnification 100X).
Fig. 3D. Immunohistochemistry showing positivity to desmin. 
Tumor cells with clear cytoplasm staining exhibiting all cellular 
phases of  myogenesis, from stellate undifferentiated cells to 
elongated myoblasts (Immunoperoxidase stain. Original mag-
nification 400X).
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and the lesions were inappropriately managed, increasing 
the patients´ morbidity.    
In the advanced stages of the disease, because of the in-
filtrative growth, and depending on the site of the tumor, 
pain, paresthesia, loosening of the teeth, and trismus occur. 
(13,14) The first patient showed involvement of the teeth as a 
consequence of tumor growth, while the second patient had 
affected teeth since the very beginning of her complaint. 
Site predilection in the oral cavity varies according to diffe-
rent authors, some finding that the palate is the commonest 
site, while others report that the tongue is the most common 
site. (14,15)  The patients described here had lesions of the 
hard palate and alveolar ridge.
CONCLUSION
Despite marked improvement in RMS survival over the past 
decades, it is known that, in addition to a poor prognosis 
for patients over ten-years old, delays in diagnosis have a 
profoundly unfavorable impact on prognosis as illustrated 
by the cases presented here. Finally, when a non-resolving 
nodule arouses suspicion, before the clinician begins anti-
biotic/anti-inflammatory therapy, support for the hypothesis 
of infection or inflammatory disease must be obtained from 
anamnesis and physical examination.  Otherwise, a biopsy 
should be performed and the patient immediately referred 
to a recognized diagnostic center. The initial management 
of any tumor is critical to a satisfactory outcome of the 
disease.  
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